![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 20, 2017 6:58:13 PM
STOCKHOLDERS’ EQUITY The Company is authorized to issue 7,500,000,000 shares of common stock and 100,000,000 shares of preferred stock as of the balance sheet date. 5,736,915,257 common shares and 80,000,000 preferred shares are issued and outstanding as of the balance sheet date. The preferred shares that were issued during the year ended December 31, 2015 have been designated as Series A Convertible Preferred Stock. Each Series A share can be converted into 1 share of common stock and has voting rights equal to 100 votes per share. They also have preferred liquidation rights equal to $0.001 per share before common shareholders. The Company also designated 10,000,000 preferred shares as Series B Convertible Preferred Stock. Each Series B share can be converted into 100 shares of common stock, but has no voting rights. They also have preferred liquidation rights equal to $1.00 per share before common shareholders. No Series B shares have been issued as of the balance sheet date.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM